Kei Kunimasa

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 25

Top Venues

Thoracic cancer

Cancer science

Cancer medicine

Oxford medical case reports

Osaka International Cancer Institute

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Osaka International Cancer Institute Apr 01 2019

Japan

Chief :: Thoracic Oncology

Publications

Takako Inoue, Kei Kunimasa, Motohiro Tamiya, Takahisa Kawamura, Toshiyuki Minami, Kazumi Nishino
Exceptionally long-lasting response to dabrafenib plus trametinib treatment in a patient with lung adenocarcinoma harboring the BRAF V600E mutation with high expression of PD-L1: A case report. Thoracic cancer (2024)
Takako Inoue, Kei Kunimasa, Motohiro Tamiya, Takahisa Kawamura, Toshiyuki Minami, Kazumi Nishino
Exceptionally long-lasting response to dabrafenib plus trametinib treatment in a patient with lung adenocarcinoma harboring the BRAF V600E mutation with high expression of PD-L1: A case report. Thoracic cancer 15 (11) (2024)
Takako Inoue, Kei Kunimasa, Motohiro Tamiya, Takahisa Kawamura, Toshiyuki Minami, Kazumi Nishino
Exceptionally long-lasting response to dabrafenib plus trametinib treatment in a patient with lung adenocarcinoma harboring the BRAF V600E mutation with high expression of PD-L1: A case report. Thoracic cancer 15 (11) (2024)
Yu Mizote, Takako Inoue, Takashi Akazawa, Kei Kunimasa, Motohiro Tamiya, Yachiyo Kumamoto, Arisa Tsuda, Satomi Yoshida, Kumiko Tatsumi, Tomoya Ekawa, Keiichiro Honma, Kazumi Nishino, Hideaki Tahara
Potent CTLs can be induced against tumor cells in an environment of lower levels of systemic MFG-E8. Cancer science 115 (4) (2024)
Yu Mizote, Takako Inoue, Takashi Akazawa, Kei Kunimasa, Motohiro Tamiya, Yachiyo Kumamoto, Arisa Tsuda, Satomi Yoshida, Kumiko Tatsumi, Tomoya Ekawa, Keiichiro Honma, Kazumi Nishino, Hideaki Tahara
Potent CTLs can be induced against tumor cells in an environment of lower levels of systemic MFG-E8. Cancer science 115 (4) (2024)
Takako Inoue, Kei Kunimasa, Motohiro Tamiya, Takahisa Kawamura, Toshiyuki Minami, Kazumi Nishino
Exceptionally long-lasting response to dabrafenib plus trametinib treatment in a patient with lung adenocarcinoma harboring the BRAF V600E mutation with high expression of PD-L1: A case report. Thoracic cancer 15 (11) (2024)
Yu Mizote, Takako Inoue, Takashi Akazawa, Kei Kunimasa, Motohiro Tamiya, Yachiyo Kumamoto, Arisa Tsuda, Satomi Yoshida, Kumiko Tatsumi, Tomoya Ekawa, Keiichiro Honma, Kazumi Nishino, Hideaki Tahara
Potent CTLs can be induced against tumor cells in an environment of lower levels of systemic MFG-E8. Cancer science (2024)
Yu Mizote, Takako Inoue, Takashi Akazawa, Kei Kunimasa, Motohiro Tamiya, Yachiyo Kumamoto, Arisa Tsuda, Satomi Yoshida, Kumiko Tatsumi, Tomoya Ekawa, Keiichiro Honma, Kazumi Nishino, Hideaki Tahara
Potent CTLs can be induced against tumor cells in an environment of lower levels of systemic MFG-E8. Cancer science 115 (4) (2024)
Takako Inoue, Kei Kunimasa, Motohiro Tamiya, Takahisa Kawamura, Toshiyuki Minami, Kazumi Nishino
Exceptionally long-lasting response to dabrafenib plus trametinib treatment in a patient with lung adenocarcinoma harboring the BRAF V600E mutation with high expression of PD-L1: A case report. Thoracic cancer 15 (11) (2024)
Yu Mizote, Takako Inoue, Takashi Akazawa, Kei Kunimasa, Motohiro Tamiya, Yachiyo Kumamoto, Arisa Tsuda, Satomi Yoshida, Kumiko Tatsumi, Tomoya Ekawa, Keiichiro Honma, Kazumi Nishino, Hideaki Tahara
Potent CTLs can be induced against tumor cells in an environment of lower levels of systemic MFG-E8. Cancer science 115 (4) (2024)
Yu Mizote, Takako Inoue, Takashi Akazawa, Kei Kunimasa, Motohiro Tamiya, Yachiyo Kumamoto, Arisa Tsuda, Satomi Yoshida, Kumiko Tatsumi, Tomoya Ekawa, Keiichiro Honma, Kazumi Nishino, Hideaki Tahara
Potent CTLs can be induced against tumor cells in an environment of lower levels of systemic MFG-E8. Cancer science 115 (4) (2024)
Kei Kunimasa, Yosuke Hirotsu, Kenji Amemiya, Keiichiro Honma, Harumi Nakamura, Kazumi Nishino, Masao Omata
Genetic dissection of intratumor heterogeneity of PD-L1 expression in EGFR-mutated lung adenocarcinoma. Thoracic cancer (2023)
Yoji Kukita, Kei Kunimasa, Takashi Akazawa, Yu Mizote, Hideaki Tahara
A Method for Extending Target Regions of Genomic Profiling by Combining a Custom Probe Pool with a Commercial Targeted Panel. The journal of applied laboratory medicine (2023)
Kei Kunimasa, Naotoshi Sugimoto, Motohiro Tamiya, Takako Inoue, Takahisa Kawamura, Ryu Kanzaki, Jiro Okami, Kazumi Nishino
Dacomitinib overcomes afatinib-refractory carcinomatous meningitis in a lung cancer patient harbouring EGFR Ex.19 deletion and G724S mutation; a case report. Investigational new drugs 40 (5) (2022)
Kei Kunimasa, Takako Inoue, Yugo Kai, Ryu Kanzaki, Sachi Kawagishi, Ken-Ichi Yoshida, Keiichiro Honma, Motohiro Tamiya, Takahisa Kawamura, Kazumi Nishino
Rapid and reliable collection of tumor tissue for successful gene panel in a patient with advanced stage lung cancer: A case report. Thoracic cancer (2022)
Kei Kunimasa, Yoshifumi Ohashi, Megumi Okawa, Hiroshi Iida, Shunji Sonoda, Yuki Hiuge, Masaaki Hachimine, Ai Yamamura, Takahisa Kawamura, Takako Inoue, Motohiro Tamiya, Hanako Kuhara, Kazumi Nishino, Naoki Nakamoto, Toru Kumagai, Hironobu Tanigami
Successful weaning of a patient with severe COVID-19 pneumonia under prolonged midazolam sedation using morphine. Oxford medical case reports 2022 (6) (2022)
Kei Kunimasa, Naotoshi Sugimoto, Takahisa Kawamura, Tomoyuki Yamasaki, Keiichirou Honma, Shigenori Nagata, Yoji Kukita, Fumie Fujisawa, Tazuko Inoue, Yuko Yamaguchi, Mitsuko Kitasaka, Toru Wakamatsu, Takuo Yamai, Sachiko Yamamoto, Takuji Hayashi, Takako Inoue, Motohiro Tamiya, Fumio Imamura, Kazuo Nishimura, Kazumi Nishino
Clinical application of comprehensive genomic profiling panel to thoracic malignancies: A single-center retrospective study. Thoracic cancer 13 (21) (2022)
Kei Kunimasa, Shingo Matsumoto, Kazumi Nishino, Keiichiro Honma, Noboru Maeda, Hanako Kuhara, Motohiro Tamiya, Takako Inoue, Takahisa Kawamura, Toru Kimura, Tomohiro Maniwa, Jiro Okami, Koichi Goto, Toru Kumagai
Comparison of sampling methods for next generation sequencing for patients with lung cancer. Cancer medicine 11 (14) (2022)
Kei Kunimasa
Is Osimertinib-Induced Cardiotoxicity Really Harmless? Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (18) (2021)
Kei Kunimasa, Takahisa Kawamura, Motohiro Tamiya, Takako Inoue, Hanako Kuhara, Kazumi Nishino, Toru Kumagai
Capmatinib successfully overcomes tepotinib-induced intolerable peripheral edema. Thoracic cancer (2021)
Hayato Kawachi, Kei Kunimasa, Yoji Kukita, Harumi Nakamura, Keiichiro Honma, Takahisa Kawamura, Takako Inoue, Motohiro Tamiya, Hanako Kuhara, Kazumi Nishino, Yu Mizote, Takashi Akazawa, Hideaki Tahara, Toru Kumagai
Atezolizumab with bevacizumab, paclitaxel and carboplatin was effective for patients with SMARCA4-deficient thoracic sarcoma. Immunotherapy 13 (10) (2021)
Fumie Fujisawa, Kei Kunimasa, Rieko Kano-Fujiwara, Yoshiharu Sato, Hiroki Kusama, Minako Nishio, Saki Matsui, Tetsuhiro Yoshinami, Nobuyoshi Kittaka, Harumi Nakamura, Shigenori Nagata, Keiichiro Honma, Toshinari Yagi, Takahiro Nakayama, Yasuhiro Tamaki, Fumio Imamura
STK11 loss drives rapid progression in a breast cancer patient resulting in pulmonary tumor thrombotic microangiopathy. Breast cancer (Tokyo, Japan) 28 (3) (2021)
Kei Kunimasa
Is the case really a SMARCA4-deficient thoracic sarcoma? Thoracic cancer 12 (1) (2020)
Kei Kunimasa, Yosuke Hirotsu, Kenji Amemiya, Yuki Nagakubo, Taichiro Goto, Yoshihiro Miyashita, Yumiko Kakizaki, Toshiharu Tsutsui, Sotaro Otake, Hiroaki Kobayashi, Rumi Higuchi, Kie Inomata, Takashi Kumagai, Hitoshi Mochizuki, Harumi Nakamura, Shin-Ichi Nakatsuka, Kazumi Nishino, Fumio Imamura, Toru Kumagai, Toshio Oyama, Masao Omata
Genome analysis of peeling archival cytology samples detects driver mutations in lung cancer. Cancer medicine 9 (13) (2020)
Kei Kunimasa, Shingo Matsumoto, Kazumi Nishino, Harumi Nakamura, Hanako Kuhara, Motohiro Tamiya, Takako Inoue, Takahisa Kawamura, Hayato Kawachi, Kika Kuno, Toru Kimura, Tomohiro Maniwa, Jiro Okami, Shin-Ichi Nakatsuka, Koichi Goto, Toru Kumagai
Improvement strategies for successful next-generation sequencing analysis of lung cancer. Future oncology (London, England) 16 (22) (2020)

Kei Kunimasa.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Kei Kunimasa